tiprankstipranks
Advertisement
Advertisement

EDSA Stock Latest News

Edesa Biotech to Showcase Positive ARDS Phase 3 Data at ATS 2026 Summit
Company AnnouncementsEdesa Biotech to Showcase Positive ARDS Phase 3 Data at ATS 2026 Summit
19d ago
EDSA
Edesa Biotech Confirms Mid-2026 Start for Phase 2 Vitiligo Trial of EB06
PremiumCompany Announcements
Edesa Biotech Confirms Mid-2026 Start for Phase 2 Vitiligo Trial of EB06
25d ago
EDSA
Edesa Biotech provides update on EB06 clinical study
PremiumThe Fly
Edesa Biotech provides update on EB06 clinical study
25d ago
EDSA
Edesa Biotech Reports Positive Phase 3 Paridiprubart Results
PremiumCompany Announcements
Edesa Biotech Reports Positive Phase 3 Paridiprubart Results
2M ago
8K
EDSA
Edesa Biotech reports additional results from Phase 3 paridiprubart study
PremiumThe Fly
Edesa Biotech reports additional results from Phase 3 paridiprubart study
2M ago
EDSA
Edesa Biotech reports Q1 EPS (28c), consensus (45c)
PremiumThe FlyEdesa Biotech reports Q1 EPS (28c), consensus (45c)
2M ago
EDSA
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
Premium
The Fly
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
4M ago
KO
COR
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025
Premium
Company Announcements
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025
4M ago
EDSA
EDSA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
EDSA Earnings this Week: How Will it Perform?
4M ago
EDSA
Edesa Biotech to Participate in Key Industry Conferences
PremiumCompany Announcements
Edesa Biotech to Participate in Key Industry Conferences
6M ago
EDSA
Edesa Biotech Announces Positive Phase 3 Study Results
PremiumCompany Announcements
Edesa Biotech Announces Positive Phase 3 Study Results
6M ago
8K
EDSA
Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint
PremiumThe Fly
Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint
6M ago
EDSA
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
PremiumCompany AnnouncementsEdesa Biotech and InflaRx: Breathing New Life into ARDS Treatment
6M ago
EDSA
IFRX
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
Premium
Company Announcements
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab
6M ago
EDSA
IFRX
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab
Premium
Company Announcements
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab
6M ago
EDSA
IFRX
JUST BREATHE: A New Hope for ARDS Treatment and Market Impact
PremiumCompany Announcements
JUST BREATHE: A New Hope for ARDS Treatment and Market Impact
6M ago
EDSA
IFRX
Edesa Biotech Amends Agreement with Canadian Government
PremiumCompany Announcements
Edesa Biotech Amends Agreement with Canadian Government
7M ago
8K
EDSA
Edesa Biotech Launches At-The-Market Offering Program
PremiumCompany Announcements
Edesa Biotech Launches At-The-Market Offering Program
7M ago
8K
EDSA
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
PremiumCompany Announcements
Edesa Biotech Advances Vitiligo Treatment Amidst Steady Financial Performance
8M ago
EDSA
EDSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsEDSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
EDSA
Edesa Biotech files $150M mixed securities shelf
Premium
The Fly
Edesa Biotech files $150M mixed securities shelf
9M ago
EDSA
Edesa Biotech’s ARDS Study: A Breath of Fresh Air for Investors?
Premium
Company Announcements
Edesa Biotech’s ARDS Study: A Breath of Fresh Air for Investors?
9M ago
EDSA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >